Fostering Trust Between Parents of Children With Cancer and Physicians
Although most parents of children with cancer form trusting relationships with their children’s oncologists, poor outcomes may negatively affect this.
Oncology
PARP Inhibitors Deemed Too Costly For Across-the-Board Frontline Maintenance in Ovarian Cancer
Broad use of PARP inhibitors to treat advanced-stage ovarian cancer would be associated with high costs compared with their biomarker-directed use.
Permanent Hair Dye Not Linked to Cancer Risk, Mortality
Use of permanent hair dye is not associated with the risk for most cancers or cancer mortality.
Challenges for Providing Psycho-Oncology Services During the Global Coronavirus Pandemic
A recent survey of UK psycho-oncology professionals highlighted the significant challenges and unexpected benefits experienced during the COVID-19 pandemic.
Immune Selection in Younger, Female Patients May Affect Driver Mutations
Immune selection in younger and female patients may influence driver mutations that persist, possibly affecting response to immune checkpoint blockade.
New Tool May Enable Less Intensive Prostate Cancer Active Surveillance
The model, based on routinely collected clinical characteristics, provides information that can enhance discussions between health care professionals and patients on active surveillance intensity.
Scientists Issue Call to Become “Antiracist” in Cancer Care and Research
Even with an “exponential growth” of URM students, “faculty diversity would remain static well into the next 50 years.”
Upended Universe: Ambiguous Loss and Grief of a Cancer Diagnosis
The uncertainty experienced due to COVID can be used to better understand the loss a patient with cancer faces after diagnosis.
High Frequency Basal Cell Carcinoma—Who is at Risk?
A study sought to establish prevalence of HF-BCC in the US and the characterization of patients with HF-BCC in the US.
Lung Cancer in the Time of COVID-19: Challenges and Solutions
In the midst of the COVID-19 pandemic, patients with lung cancer face an increased risk of disease progression, reduced survival, and worse quality of life associated with delayed treatment.
-
Loading...
-
Loading...
